Investigation Report on Chinese Imatinib Market, 2018-2022

SKU ID :CRI-11994621 | Published Date: 11-Jul-2018 | No. of pages: 30
Table of Contents 1 Basic Concepts of Imatinib 1.1 Indications for Imatinib 1.2 Development History of Imatinib in China 1.3 Governmental Approval of Imatinib in China 2 Sales of Imatinib in China, 2013-2017 2.1 Overall Sales of Imatinib 2.1.1 Sales Value 2.1.2 Sales Volume 2.2 Sales of Imatinib in Key Regions of China 2.2.1 Sales Value 2.2.2 Sales Volume 2.3 Sales of Imatinib by Dosage Form 2.4 Imatinib Smuggled to China 3 Analysis on Major Imatinib Manufacturers in China 3.1 Overview of Major Competitors 3.1.1 Market Share by Sales Value 3.1.2 Market Share by Sales Volume 3.2 Novartis 3.2.1 Enterprise Profile 3.2.2 Sales of Novartis's Imatinib (Gleevec) in China 3.3 Jiangsu Hansoh Pharmaceutical Co., Ltd. 3.3.1 Enterprise Profile 3.3.2 Sales of Hansoh Pharmaceutical's Imatinib (Xinwei) in China 3.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 3.4.1 Enterprise Profile 3.4.2 Sales of Chia Tai Tianqing Pharmaceutical's Imatinib (Genike) in China 3.5 CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. 4 Prices of Imatinib in China, 2017-2018 4.1 Analysis on Average Price of Imatinib in China 4.1.1 Overall Price 4.1.2 Average Price by Region 4.2 Imatinib Price by Enterprise 4.2.1 Novartis (Gleevec) 4.2.2 Jiangsu Hansoh Pharmaceutical Co., Ltd. (Xinwei) 4.2.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Genike) 4.2.4 CSPC Zhongqi Pharmaceutical Technology Co., Ltd. 5 Prospects of Chinese Imatinib Market, 2018-2022 5.1 Analysis on Factors Influencing Imatinib Development 5.1.1 Driving Forces 5.1.2 Unfavorable Factors 5.2 Forecast on Competition Pattern 5.3 Forecast on Market Size Table of Charts Chart Patents of Imatinib in China Chart Governmental Approval of Imatinib in China Chart Sales Value of Imatinib in China, 2013-2017 Chart Sales Value of Imatinib in Parts of China, 2013-2017 Chart Sales Volume of Imatinib in China, 2013-2017 Chart Market Share and Sales Value of Imatinib of Novartis (Switzerland) in China, 2013-2017 Chart Market Share and Sales Value of Hansoh Pharmaceutical's Imatinib in China, 2013-2017 Chart Market Share and Sales Value of Chia Tai Tianqing Pharmaceutical's Imatinib in China, 2013-2017 Chart Sales Value and Market Share of Imatinib Tablets in China, 2013-2017 Chart Sales Value and Market Share of Imatinib Capsules in China, 2013-2017 Chart Prices of Chia Tai Tianqing Pharmaceutical's Imatinib in Several Chinese Cities, 2017-2018 Chart Prices of Hansoh Pharmaceutical's Imatinib in Several Chinese Cities, 2017-2018 Chart Prices of Novartis's Imatinib (Gleevec) in Several Chinese Cities, 2017-2018 Chart Forecast on Sales Value of Imatinib in China, 2018-2012
Novartis Jiangsu Hansoh Pharmaceutical Co., Ltd. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
  • PRICE
  • $2200
    $3300

Our Clients